Cabulong, Blaise .
HRN: 17-08-27 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2025
CEFUROXIME 1.5GM (VIAL)
10/21/2025
10/22/2025
IV
1.5g
X2 Doses
S/p Cs
Waiting Final Action
10/22/2025
CEFUROXIME 500MG (TAB)
10/22/2025
10/29/2025
ORAL
500 Mg
Bid
S/p Cs
Waiting Final Action